
RxSight (RXST) Stock Forecast & Price Target
RxSight (RXST) Analyst Ratings
Bulls say
RxSight is well positioned for long-term success due to its unique customizable intraocular lens technology, growing adoption rates, and strong financial performance with a gross margin well above consensus and operating expenses down compared to the previous year. However, risks to consider include potential challenges in commercial execution, competition in the market, and the need for additional financing. Upside drivers could include faster than expected growth in installed base and higher utilization. Overall, the company has promising potential and a solid foundation for future growth.
Bears say
RxSight is currently facing significant headwinds due to slower revenue growth and lower LDD placements, leading to cash burn. The company's 2026 guidance falls short of analysts' expectations, and their lower unit growth in LALs and LDDs is concerning. Additionally, their revenue mix and GM may be negatively impacted by higher-priced inventory and lower LDD sales in 2H26. Their progress OUS is promising, but may not generate meaningful revenue in the near term.
This aggregate rating is based on analysts' research of RxSight and is not a guaranteed prediction by Public.com or investment advice.
RxSight (RXST) Analyst Forecast & Price Prediction
Start investing in RxSight (RXST)
Order type
Buy in
Order amount
Est. shares
0 shares